2019-08-17 8. 5F 504講堂Room 504
時間主題
15:30 ~ 15:50
瀏覽海報時間
講者: All 座長: 王賢祥,
黃雲慶
15:50 ~ 15:54
MP021: Real world experience of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
講者: 方仁愷 座長: 王賢祥,
黃雲慶
15:54 ~ 15:58
MP022: Robotic radical prostatectomy for pathologic locally advanced prostate cancer, including pT3a, pT3b, pT4, and any TN1: single team experience
講者: 張英傑 座長: 王賢祥,
黃雲慶
15:58 ~ 16:02
MP023: Comparisons of robot assisted radical prostatectomy and high intensity focused ultrasound for the treatment of prostate cancer: single center experience
講者: 張殷綸 座長: 王賢祥,
黃雲慶
16:02 ~ 16:06
MP024: The treatment result of radium-223 on metastatic castration-resistant prostate cancer patients – experience in Taipei Veterans General Hospital
講者: 余秉軒 座長: 王賢祥,
黃雲慶
16:06 ~ 16:10
MP025: Salvage high intensity focused ultrasound, cryoablation or radiotherapy after primary treatment of localized prostate cancer
講者: 江品葭 座長: 王賢祥,
黃雲慶
16:10 ~ 16:14
MP026: AICAR induces apoptosis and inhibits migration of prostate cancer cells through an AMPK/mTOR-dependent pathway
講者: 蘇家震 座長: 王賢祥,
黃雲慶
16:14 ~ 16:18
MP027: Robotic partial nephrectomy for > 4cm renal cell carcinoma: single center experience
講者: 張英傑 座長: 王賢祥,
黃雲慶
16:18 ~ 16:22
MP028: The efficacy of abiraterone and enzalutamide in a real life situation- the experience from Tung’s Taichung MetroHarbor Hospital
講者: 盧顥文 座長: 王賢祥,
黃雲慶
16:22 ~ 16:26
MP029: Radium-223 in the treatment of metastatic prostate cancer: preliminary experience in Taiwan
講者: 陳柏諺 座長: 王賢祥,
黃雲慶
16:26 ~ 16:30
MP030: Early dutasteride monotherapy in men with elevated serum prostate-specific antigen levels following robot-assisted radical prostatectomy
講者: 呂謹亨 座長: 王賢祥,
黃雲慶